Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma
Bladder carcinoma is globally among the most prevalent cancers and is associated with a high mortality rate at advanced stages. Its detection relies on invasive diagnostic methods that are unpleasant for the patient. Non-invasive molecular biomarkers, such as miRNAs, could serve as alternatives for...
Main Authors: | Maria Samara, Panagiotis J. Vlachostergios, Eleni Thodou, Ioannis Zachos, Lampros Mitrakas, Konstantinos Evmorfopoulos, Vassilios Tzortzis, Antonis Giakountis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/22/16243 |
Similar Items
-
Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features
by: Panagiotis J. Vlachostergios, et al.
Published: (2022-11-01) -
Upper Tract Urothelial Carcinoma: A Rare Malignancy with Distinct Immuno-Genomic Features in the Era of Precision-Based Therapies
by: Konstantinos Evmorfopoulos, et al.
Published: (2023-06-01) -
The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer
by: Maria Iyali Torres-Bustamante, et al.
Published: (2024-02-01) -
Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer
by: Xiao-Hong Yin, et al.
Published: (2019-08-01) -
Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker
by: Xuan-Mei Piao, et al.
Published: (2021-02-01)